Search Results (8,074)

Background/Objectives: The emergence of antimicrobial-resistant (AMR) pathogens in aquaculture ecosystems poses a significant risk to both food security and human health. Shewanella species are recognized as significant AMR reservoirs, yet their prevalence and resistance mechanisms within a shrimp-related ecosystem remain poorly characterized. This study aimed to perform a genotypic and phenotypic characterization of S. algae VK101, isolated from wild-caught black tiger shrimp (Penaeus monodon) broodstock. Methods: A complete 5.21 Mb genome was generated using a hybrid Illumina and Oxford Nanopore sequencing approach. Antimicrobial susceptibility was evaluated for 21 antibiotics via Minimum Inhibitory Concentration (MIC) testing. Comparative pangenomics and genome-wide association studies (GWAS) across 125 S. algae genomes were conducted to identify novel resistance determinants. Results: MIC analysis revealed that VK101 was resistant to ampicillin (>16 µg/mL) and colistin (8 µg/mL), while showing intermediate susceptibility to imipenem and ciprofloxacin. In silico analysis identified 205 antimicrobial resistance genes (ARGs), including a perfect hit for the fluoroquinolone resistance gene qnrA3. Notably, no mcr genes were detected. Although VK101 exhibited moderate resistance (8 µg/mL), GWAS across the broader S. algae population linked a specific lptA mutation (K140N) to high-level resistance (64 µg/mL). Other GWAS-identified genes (e.g., czcA, ampC, and oprM) likely represent indirect associations driven by genetic linkage or clade-specific markers rather than direct causal factors. Conclusions: These findings highlighted the presence of multidrug-resistant S. algae in wild-caught P. monodon broodstock, reflecting the occurrence of antimicrobial resistance in aquatic environments. Colistin resistance in these isolates was primarily mediated by chromosomal variants rather than mobile mcr elements, indicating the need for integrated genomic surveillance within the aquaculture value chain. Full article

The high prevalence of biofilm-associated multidrug-resistant (MDR) Escherichia coli infections in older adults calls for novel control strategies. This study compared fecal E. coli carriage, antimicrobial resistance, and biofilm formation among community-dwelling older adults with different self-reported immune statuses (lower vs. normal), and evaluated the antibiofilm activity of five Lactobacillus cell-free supernatants (CFSs). Fecal samples from 20 older adults were analyzed. E. coli was enumerated, and isolates were characterized for antimicrobial susceptibility and biofilm formation. Five Lactobacillus strains were screened for antibiofilm activity using crystal violet assay, with further evaluation of extracellular polymeric substance (EPS) production and biofilm morphology. After removing the redundant isolates, 70 isolates were reported, with significantly higher counts in the lower-immunity group (7.89 vs. 6.04 log MPN/g). The lower-immunity group had significantly higher antimicrobial resistance (97.3% vs. 60.6%), and higher MDR prevalence (91.7% vs. 24.2%). Biofilm formation was observed in 62.9% of isolates, with significantly higher prevalence among MDR isolates and in the lower-immunity group. L. paracasei L475 CFS showed the strongest antibiofilm activity against a representative MDR isolate (L5-1), with inhibition and eradication rates of 82.9% and 75.0%, respectively. Mechanistically, L475 CFS reduced extracellular polymeric substance components, with a 92.3% reduction in proteins and 41.3% in polysaccharides. Microscopy confirmed disrupted biofilm architecture, membrane damage, and cell lysis. In conclusion, these preliminary findings indicate a potential association between self-reported immune function and E. coli resistance/biofilm formation in older adults. L. paracasei L475 CFS demonstrates promising in vitro antibiofilm activity against an MDR E. coli isolate from this population, supporting its potential as a postbiotic candidate. Full article

Camel-associated antimicrobial resistance (AMR) is an underrecognized component of the One Health landscape, particularly in the Gulf Cooperation Council (GCC) and North Africa. Available evidence demonstrates the presence of clinically significant resistance mechanisms in camel populations, including extended-spectrum beta-lactamases, carbapenemases, colistin resistance genes, and multidrug-resistant clones. Molecular similarities between camel and human isolates suggest potential cross-species transmission and highlight camels as possible reservoirs within interconnected human–animal–environment systems. Despite documented resistance patterns, camel production systems remain largely excluded from national AMR surveillance and stewardship frameworks. This gap reflects limited camel-specific data on antimicrobial usage and structural challenges related to pastoral mobility, cross-border trade, and emerging commercial intensification. Strengthening diagnostic capacity, implementing tailored antimicrobial stewardship strategies, and integrating camels into national AMR action plans are essential to mitigate potential public health risks. Proactive inclusion of camel systems within regional AMR governance frameworks is necessary to prevent further amplification of resistance. Full article

Silver nanoparticles (AgNPs) are widely recognized for their potent antibacterial properties and diverse biomedical applications. While conventional synthesis methods typically rely on chemical-reducing agents that may pose risks to human health and the environment, this study proposes an eco-friendly green synthesis approach utilizing porcine skin extracts. The extracts were prepared through thermal treatment and filtration to serve as a biological reducing agent. Successful synthesis was validated using dynamic light scattering, Fourier transform infrared (FTIR) spectroscopy, UV–Vis spectroscopy, and scanning electron microscopy (SEM). Furthermore, the antimicrobial efficacy of the synthesized AgNPs was evaluated against multidrug-resistant microorganisms, demonstrating significant growth inhibition across various antibiotic-resistant strains. These findings suggest that porcine skin—a readily available bioresource—is a promising precursor for the sustainable production of AgNPs with broad-spectrum antimicrobial potential. Full article

Multidrug-resistant (MDR) Salmonella enteritidis infections cause high mortality and devastating economic losses in poultry, pose severe threats to animal health and food safety, and create an urgent demand for effective antibiotic alternatives. Herein, we developed a cationic liposome-encapsulated bacteriophage endolysin Lys40 (designated Lys40-Lip), and systematically evaluated its therapeutic efficacy in a chick model challenged with Salmonella enteritidis strain S4. Recombinant Lys40 was encapsulated into cationic liposomes with an encapsulation efficiency (EE) of 34.83%. The resulting Lys40-Lip nanoparticles had a hydrodynamic diameter of 137.3 ± 4.1 nm, a high positive zeta potential of +42.5 ± 0.3 mV, and excellent stability, retaining 78.52% of its initial bactericidal activity after 56 days of storage at 4 °C. Following a three-day oral treatment in Salmonella enteritidis S4-infected chicks, Lys40-Lip significantly increased survival rates in a dose-dependent manner (72.22% to 88.89% for low-to-high dose vs. 44.44% in infected controls, p < 0.05) and reduced ileal Salmonella enteritidis S4 colonization by 28.8% compared to free Lys40. Histopathology revealed Lys40-Lip restored duodenal villus integrity and reduced jejunal and ileal inflammation. Serum cytokine analysis confirmed that Lys40-Lip effectively regulated the host inflammatory response, significantly downregulating the pro-inflammatory cytokines IL-1β and IL-6, and upregulating the anti-inflammatory cytokine IL-10. Crucially, liposomal encapsulation overcame the outer membrane barrier of Gram-negative bacteria via charge-driven fusion mediated by its high positive surface potential (+42.5 ± 0.3 mV), enabling targeted delivery of Lys40 without the need for EDTA or other outer membrane permeabilizers. Lys40-Lip significantly improved the therapeutic outcomes of avian salmonellosis via synergistic direct bactericidal activity, intestinal barrier protection and inflammatory response regulation, offering a promising nanotherapeutic strategy for the control of this disease in veterinary practice. Full article

To date, the problem of mastitis in cattle remains relevant for both the industrial sector and scientific research. Despite numerous active investigations, the causes of this disease have not been fully established. It is postulated that several factors may be involved, such as bacterial pathogens, animal husbandry practices, and weather and climatic conditions. In this study, we selected cows from farms in Yakutia to investigate microbial isolates present in the milk of cows affected by mastitis and treated with antibiotics. Five identified Staphylococcus aureus isolates were investigated using whole-genome sequencing (Illumina sequencing and nanopore sequencing), followed by analysis of virulence factors in the genomes and cultural properties of the isolates. The profile of S. aureus virulence genes (exotoxins, cytotoxins, superantigen-like proteins, adhesins) was identified via WGS. Hemolysin gene (hla) was detected in all isolates. An investigation of the cultural properties of the isolates, specifically through hemolysis of rabbit erythrocytes and Western blot analysis of the culture liquid of S. aureus, revealed different expression levels of alpha-hemolysin among the strains. One isolate (17-21) exhibited the highest secretion level of about 320 ± 37 ng, both in the hemolysis test and immunoblotting assay. An investigation of the isolates’ antibiotic resistance showed that all isolates exhibited multidrug resistance, as confirmed by the presence of antibiotic resistance genes in these isolates. One isolate (7-7) exhibited the broadest range of phenotypic resistance and was resistant to all tested antibiotics (except clindamycin). Phylogenetic analysis suggested that the evolution of these isolates occurred independently in their respective ecological niches, although their transfer from cattle to humans, and vice versa, is possible. Isolates 7-7, 18-22, 33-40, and 35-42 are most typical to Yakutian cattle, while isolate 17-21 might have been introduced from a different region. To the best of our knowledge, this is the first in-depth study into a range of S. aureus isolates associated with mastitis infection in Yakutian cattle. Full article

Campylobacter jejuni is a major zoonotic pathogen that circulates among birds, livestock, humans, and environmental reservoirs, yet the genomic mechanisms that enable persistence and transmission across divergent hosts remain incompletely understood. Here, we sequenced 61 C. jejuni isolates recovered from multiple host-associated sources in Shenzhen, China, from 2016 to 2023, and analyzed them together with 312 dereplicated publicly available high-quality reference genomes. Phylogenomic analyses resolved three major clades, including one avian-restricted clade and two clades showing frequent cross-host occurrence. Human-associated isolates displayed lower coding density than mammal-associated isolates and significantly higher proteome-level carbon and nitrogen demands than avian-associated isolates. Comparative genomic analyses further revealed strong host-associated divergence in chromosome-encoded, plasmid-encoded, and horizontally acquired gene repertoires. In human-derived isolates, 11 dataset-specific human-unique KEGG genes and 48 human-unique virulence-associated genes were identified, and human-associated strains showed the strongest multidrug-resistance signal across both chromosome-encoded and mobile-gene compartments. Resistance-associated functions enriched in human-associated genomes included antibiotic inactivation, efflux-mediated resistance, target protection/replacement/alteration, reduced permeability, and nutrient-acquisition-associated resistance. By contrast, core host-interaction loci remained under strong purifying selection, indicating that major human-associated traits were linked more closely to mobile gene acquisition than to extensive mutation-driven diversification. Together, these findings support a proposed genome-partition framework of host adaptation in C. jejuni, in which relatively stable chromosomal backgrounds are complemented by rapid plasmid- and horizontal-transfer-mediated acquisition of high-impact accessory genes. Full article

Multidrug resistance (MDR) and chemotherapy-associated toxicity remain major challenges limiting the success of cancer treatments. In this context, berberine (BBR), an isoquinoline derivative belonging to the barberry family, has emerged as a promising adjuvant that can enhance the efficacy of chemotherapy while potentially mitigating its side effects. The findings indicate that berberine enhances the therapeutic effect of several drugs, such as doxorubicin, cisplatin, tamoxifen, and 5-fluorouracil, through multiple mechanisms including the inhibition of ABC transporters, regulation of autophagy, and synergistic enhancement of reactive oxygen species generation. Advanced pharmaceutical and nanotechnological formulations, including cyclodextrin complexes, solid dispersions, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, chitosan-based systems, and inorganic nanoplatforms, have demonstrated significant improvements in the solubility, stability, cellular uptake, and oral bioavailability of berberine. However, knowledge gaps remain regarding optimal dosage determination, safety assessment in combination therapy, and establishing efficacy in large-scale clinical trials. Incorporating berberine into combination therapy strategies may improve treatment outcomes, overcome drug resistance, and potentially reduce the toxic burden associated with chemotherapy. Therefore, this review provides a comprehensive analytical framework for berberine’s potential as an adjuvant, elucidates its mechanistic synergistic interactions with standard therapies, explores pharmaceutical strategies to overcome bioavailability limitations, and suggests future research avenues to further its clinical development. Full article

Uropathogenic Escherichia coli (UPEC) is a leading cause of urinary tract infections (UTIs) in companion animals. This study characterized 42 UPEC isolates recovered from dogs and cats at the University of Florida, College of Veterinary Medicine Diagnostic Laboratories between 2023 and 2024, focusing on antimicrobial resistance (AMR), virulence gene profiles, biofilm-forming ability, and phylogroup distribution of the isolates. Antimicrobial susceptibility testing (AST) showed that 40.48% of the isolates were resistant to at least one of the tested antibiotics, and 9.52% exhibited multidrug resistance (MDR). Phylogroup B2 was predominant (69.05%), and 61.90% of isolates demonstrated strong biofilm formation in artificial human urine. Virulence gene analysis revealed the presence of genes mediating adhesion (fim, pap, sfa), iron acquisition (fyuA, iro), biofilm formation (csg, bcs, pga, ycg/ymg), motility (fli, mot, flh), and stress response (oxyR, soxR/S, kat). Multiple plasmids carrying AMR and virulence determinants were also identified. The co-occurrence of the traits underscores the potential for persistent and recurrent infections, which can complicate therapeutic outcomes and facilitate horizontal gene transfer (HGT). The detection of antimicrobial-resistant, highly virulent UPEC strains possessing human UPEC traits in companion animals suggests the risk of zoonotic and reverse-zoonotic transmission, particularly in households with close pet–owner interactions. These findings emphasize the importance of judicious antimicrobial use, routine molecular surveillance, and integrated One Health strategies to mitigate the veterinary and public health threats associated with UPEC infections in companion animals. Full article

The efficacy of traditional antimicrobial treatments has been largely compromised due to the high occurrence of multidrug-resistant (MDR) pathogens, therefore underlining the limitations of existing drug delivery mechanisms. Pathogens resist pharmacological treatment via different mechanisms, including efflux pump overexpression, biofilm formation, and enzymatic destruction. The application of nanorobotics or controllable nanoscale devices has gained considerable attention for overcoming shortcomings while connecting biomedical engineering, materials science, and microbiology. Despite advancements in nanomedicine, there is still no suitable nanorobotic system applicable against MDR pathogens. Previous studies highlighted device categories and materials but did not explain the detailed nanorobotic mobility, sensing, and programmability to counteract biological resistance. This review combines cross-disciplinary discoveries to design a mechanistic and translational model for nanorobotics effective in controlling infectious diseases while focusing on the advancements in nanorobotic technologies over the past six years (2020–2025), with emphasis on translational readiness, biosafety issues, scalability, regulation, and their mechanistic ability to overwhelm MDR complications. Databases from different publishers, including PubMed, Scopus, and Web of Science, were used to select studies focusing on the potential of emerging nanorobotic therapeutic technologies, such as magnetic microrobots, catalytic nanoswimmers, and DNA origami nanodevices, and their application to bacterial biofilms and antibiotic drug delivery. Evidence from the literature shows that magnetically driven microrobots, catalytic nanoswimmers, and DNA origami structures can actively destroy biofilms, enhance antibiotic penetration, and perform site-specific antimicrobial administration. Nevertheless, most of these innovations remain in the preclinical or prototype stage, hindered by biosafety issues, immunological reactivity, poor routing precision, energy source optimization, and a lack of regulatory and ethical frameworks, which are major challenges for clinical translation. Full article

Background/Objectives: Multidrug-resistant (MDR) Escherichia coli has increasingly been recognized as a pathogen capable of causing severe systemic infections in various animal species. However, reports describing respiratory and septicemic infections caused by MDR E. coli in guinea pigs remain scarce. The objective of this report was to describe the clinical, pathological, and microbiological findings associated with a fatal infection in a domestic guinea pig. Case Study: A 10-month-old female guinea pig (Cavia porcellus), kept as a companion animal in a household environment, presented with acute respiratory distress, lethargy, and anorexia, progressing rapidly to death within approximately 36 h of onset. Post-mortem examination revealed severe pulmonary congestion, diffuse inflammatory lesions in the trachea, and generalized vascular congestion in multiple organs. Bacteriological cultures obtained from lung and bone marrow samples yielded pure growth of Escherichia coli. Identification was confirmed using MALDI-TOF mass spectrometry. Antimicrobial susceptibility testing demonstrated resistance to several antibiotic classes, including β-lactams, fluoroquinolones, tetracyclines, sulfonamides, and phenicols, while susceptibility was retained only to aminoglycosides. Molecular analysis revealed the presence of virulence genes involved in adhesion and iron acquisition, supporting the pathogenic potential of the isolate. Conclusions: This report highlights the ability of MDR E. coli to cause severe respiratory and systemic infections in guinea pigs. The findings underline the importance of early diagnosis, appropriate antimicrobial stewardship, and improved husbandry conditions in preventing such infections. From a One Health perspective, the circulation of resistant strains in companion animals may represent a potential risk for both environmental and human health. Full article

Background/Objectives: The WHO has identified carbapenem-resistant Acinetobacter baumannii (CRAb) and carbapenem-producing Enterobacterales (CPE) as the “critical priority” group of multidrug-resistant (MDR) organisms for which new therapeutic strategies are urgently needed. Here, we evaluated the in vitro synergistic activity of eugenol, cinnamaldehyde, and carvacrol in combination with β-lactams, gentamicin, or colistin against MDR Gram-negative bacteria (GNB). Methods: We selected seven MDR-GNB clinical isolates including CRAb, ESBL-producing and CPE clinical isolates displaying different antimicrobial susceptibility profiles. The genomes of clinical isolates were characterized by whole-genome sequencing and synergy testing was performed with checkerboard assay. Results: Our results demonstrate that eugenol, cinnamaldehyde, and carvacrol in combination with colistin exhibited synergistic activity (FICI < 0.5) against MDR-GNB clinical isolates ranging from 37.5 to 50%, while the effect was almost indifferent in combination with different β-lactam molecules or gentamicin against 87.5–100% of MDR-GNB strains. The synergistic interaction of eugenol, cinnamaldehyde, and carvacrol with colistin induced a statistically significant reduction (p < 0.05) in the MIC values compared with the molecules tested alone. Conclusions: Our data demonstrate that this synergistic interaction was not affected by different antimicrobial resistance genes and/or different antimicrobial susceptibility profiles. In conclusion, our results suggest that eugenol, cinnamaldehyde, and carvacrol in combination with colistin represent a potential strategy for the treatment of MDR-GNB pathogens and limit their diffusion. Full article

This study investigated the microbiological composition and antimicrobial resistance (AMR) profiles of artisanal goat and sheep milk cheeses produced in Poland. Ten raw milk cheeses (five each from goat and sheep milk) were analyzed using a combined approach involving culture-dependent enumeration, 16S rRNA gene sequencing, and antibiotic susceptibility testing. Microbial counts revealed substantial variability among the samples, with lactic acid bacteria (LAB) dominating the microbiota. Taxonomic analysis confirmed the predominance of Lactococcus, Streptococcus, and lactobacilli, although marked intra-group heterogeneity was observed. Multivariate analyses indicated that sample-specific factors had a greater influence on microbiome composition than milk origin. Among 170 isolates, 28.7% were classified as multidrug-resistant (MDR), being most prevalent in Enterobacterales (100%) and Enterococcus spp. (73%), whereas LAB exhibited low resistance levels (16.2%). Resistance was most frequently associated with aminoglycosides and β-lactams. The resistance results were interpreted according to CLSI guidelines. These findings demonstrate that artisanal cheeses harbor complex, dynamic microbial ecosystems that may serve as reservoirs of antimicrobial resistance. The results highlight that environmental and technological factors, rather than milk source alone, are key drivers of both microbiome structure and resistance distribution, underscoring the need for targeted AMR monitoring in traditional dairy products. Full article

Antimicrobial peptides (AMPs) have re-emerged as promising anti-infective agents, particularly against multidrug-resistant bacteria; however, their therapeutic development remains constrained by proteolytic degradation, host cell toxicity, and rapid systemic clearance. Rather than focusing solely on sequence discovery, recent efforts have shifted toward structural and supramolecular modification strategies aimed at improving stability, selectivity, and pharmacological performance. This review critically analyzes intramolecular modifications—including phosphorylation, glycosylation, acetylation, methylation, and backbone cyclization—that modulate peptide conformation and resistance to enzymatic degradation. In parallel, extramolecular approaches such as PEGylation, lipidation, and conjugation to antibiotics, siderophores, or antibodies are examined in the context of enhanced targeting and prolonged bioavailability. Particular emphasis is placed on localized delivery systems, including hydrogels, polymeric films, and nanofibrous scaffolds, which enable spatially controlled administration and mitigate systemic exposure. By integrating evidence from ex vivo and in vivo infection models, this work delineates the translational potential and remaining bottlenecks of chemically engineered AMP platforms for skin and soft tissue infections. Full article

Background: Enterobacter hormaechei, a member of the Enterobacter cloacae complex (ECC), is increasingly recognized as a multidrug-resistant (MDR) nosocomial pathogen. However, subspecies-level genomic data from Ecuador remain limited. Methods: Four clinical E. hormaechei isolates from a hospital in northern Ecuador were analyzed using antimicrobial susceptibility testing and whole-genome sequencing (WGS). Genomic characterization included multilocus sequence typing (MLST), resistome profiling, plasmid replicon detection, integron screening, genomic island analysis, and phylogenetic comparison with publicly available Ecuadorian genomes. Results: WGS identified three isolates as subsp. xiangfangensis (ST136 and ST337) and one as subsp. hoffmannii (ST145). Two ST136 isolates exhibited extensive MDR phenotypes associated with bla_CTX-M-15, bla_OXA-1, bla_ACT-16, and additional aminoglycoside and fluoroquinolone resistance genes. ST145 showed moderate resistance, whereas ST337 remained largely susceptible despite harboring bla_ACT-16. Multiple genomic islands and plasmid replicons (IncF/IncR or IncHI2) were detected. Phylogenetic analysis demonstrated clustering with previously reported Ecuadorian lineages. Conclusions: This study provides subspecies-level genomic characterization of clinical E. hormaechei in Ecuador and describes heterogeneous resistance profiles and associated mobile genetic elements, contributing baseline data for regional surveillance. Full article